Improving diabetes care for Latinos using e-health tools
Latinos Understanding the Need for Adherence in Diabetes Using Care Coordination, Integrated Medical and Behavioral Care and E-Health
This study is testing whether using online tools and support can help Latino patients with type 2 diabetes manage their condition better and feel less stressed.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 400 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | San Diego State University Academic / other |
| Locations | 1 site (Chula Vista, California) |
| Trial ID | NCT05570734 on ClinicalTrials.gov |
What this trial studies
The LUNA-E project is a randomized controlled trial aimed at enhancing diabetes management among Latino patients through a patient-centered, team-based approach that incorporates e-health technologies. The study will enroll 400 participants with type 2 diabetes from a federally qualified health center, focusing on improving glycemic control and reducing psychological distress. Participants will receive care coordination, behavioral health support, and health education via virtual visits and videos. Biological and psychosocial measures will be collected at multiple time points to assess the intervention's effectiveness.
Who should consider this trial
Good fit: Ideal candidates are Latino adults aged 18 and older with type 2 diabetes and a hemoglobin A1C level greater than 7.5%.
Not a fit: Patients with severe diabetes complications or those actively treated for other serious health conditions may not benefit from this study.
Why it matters
Potential benefit: If successful, this intervention could significantly improve diabetes management and mental health outcomes for Latino patients.
How similar studies have performed: Other studies have shown promise in using technology and community-based approaches for diabetes management, suggesting potential success for this intervention.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Self identify as Hispanic/Latino ethnicity of any race 2. Registered patient of federally qualified health center 3. 18 years of age or older 4. Type 2 diabetes with hemoglobin A1C (HbA1c) \>7.5% in past 90 days 5. Approval from primary care provider 6. Not currently enrolled/participating in any other diabetes intervention program(s) Exclusion Criteria: 1. Actively being treated for cancer or Parkinson's Disease 2. Pregnant or nursing (temporary exclusion, may qualify 6-months postpartum) 3. Have plans to move out of the area in the next 12 months 4. Have other existing mental or physical health problems so severe as to prohibit informed consent and participation 5. Have severe diabetes complications (e.g., renal disease, or on dialysis)
Where this trial is running
Chula Vista, California
- South Bay Latino Research Center — Chula Vista, California, United States (Recruiting)
Study contacts
- Principal investigator: Gregory A Talavera, MD/MPH — San Diego State University
- Study coordinator: Program Manager
- Email: pmendoza@sdsu.edu
- Phone: 619-594-8060
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.